Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Higher dose maximizes effects of magnesium sulfate for obese women
Key clinical point: A dosing regimen of 6 g IV loading followed by 2-g/hour IV infusion yielded more reliable serum magnesium concentrations than a 4 g IV loading followed by 1-g/hour infusion for obese women.
Major finding: After 4 hours, magnesium sulfate concentrations were significantly higher for women in the high-dose group vs. the standard group (4.41 mg/dL vs. 3.53 mg/dL).
Study details: The data come from a randomized trial of 37 obese women with preeclampsia enrolled between July 12, 2016, and March 14, 2019.
Disclosures: The study was supported by the National Institutes of Health Loan Repayment Program and a Mission Support Award from Oregon Health & Science University to Dr. Brookfield and by the Oregon Clinical & Translational Research Institute grant. Dr. Brookfield also disclosed funding from the World Health Organization. Dr. Sibai had no financial conflicts to disclose.
Brookfield KF et al. Obstet Gynecol. 2020 Dec. doi: 10.1097/AOG.0000000000004137.